Outset Medical (Outset Medical) Long-Term Capital Lease Obligation : $4.1 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Outset Medical Long-Term Capital Lease Obligation?

Outset Medical's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $4.1 Mil.

Outset Medical's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 ($4.9 Mil) to Dec. 2023 ($4.5 Mil) and declined from Dec. 2023 ($4.5 Mil) to Mar. 2024 ($4.1 Mil).

Outset Medical's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($6.9 Mil) to Dec. 2022 ($5.6 Mil) and declined from Dec. 2022 ($5.6 Mil) to Dec. 2023 ($4.5 Mil).

Outset Medical Long-Term Capital Lease Obligation Historical Data

The historical data trend for Outset Medical's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Outset Medical Long-Term Capital Lease Obligation Chart

Outset Medical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

8.04

6.89

5.58

4.48

Outset Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															5.22	5.31	4.90	4.48	4.05

Outset Medical (NAS:OM) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Outset Medical Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Outset Medical's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Outset Medical (Outset Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Outset Medical Inc (NAS:OM) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

3052 Orchard Drive, San Jose, CA, USA, 95134

Website

https://www.outsetmedical.com

Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

Executives

Leslie Trigg	director, officer: President & CEO	C/O OUTSET MEDICAL, 1830 BERING ROAD, SAN JOSE CA 95112
Marc Nash	officer: SVP, Operations and R&D	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Jean-olivier Racine	officer: Chief Technology Officer	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Nabeel Ahmed	officer: Interim CFO	3052 ORCHARD DRIVE, SAN JOSE CA 95134
Stacey L. Porter	officer: Chief People Officer	3052 ORCHARD DRIVE, SAN JOSE CA 95134
John L. Brottem	officer: General Counsel	3052 ORCHARD DR., SAN JOSE CA 95134
Steven S. Williamson	officer: Chief Commercial Officer	C/O HOLOGIC, INC., BEDFORD MA 01730
Martin Vazquez	officer: Chief Operating Officer	3052 ORCHARD DR., SAN JOSE CA 95134
James F. Hinrichs	director	3750 TORREY VIEW COURT, SAN DIEGO CA 92130
Dale E Jones	director	C/O HUGHES SUPPLY INC, 20 N ORANGE AVE, ORLANDO FL 32801
D Keith Grossman	director
Rebecca Chambers	officer: Chief Financial Officer	3052 ORCHARD DR., SAN JOSE CA 95134
Catherine M. Szyman	director	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Warburg Pincus Llc	director, 10 percent owner	450 LEXINGTON AVENUE, NEW YORK NY 10017
Warburg Pincus X, L.p.	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017